Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Effectiveness and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder Who Do Not Show Early Improvement Following Antidepressant Treatment: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

NCT06692361 is registered in ClinicalTrials.gov with Gang Wang as lead sponsor.

NCT NCT06692361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06692361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Effectiveness and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder Who Do Not Show Early Improvement Following Antidepressant Treatment: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Lead sponsor
Gang Wang
Phase
Not applicable
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2026
Enrollment
214 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

depression - major depressive disorder, major depressive disorder (mdd)